⚠️ 35 settlements closing this week 1 day left →

Hetero Valsartan $11.37M Drug

Other
1 Settlement
$11M Total Paid
2026 Last Settled

Based on 1 class action settlement in our database, Hetero Valsartan $11.37M Drug earns a grade of D on corporate accountability.

Share this grade:
D Grade 57/100

Grade Breakdown

📊
Settlements on Record
1
30% of grade
💰
Total Settlement Amount
$11.4M
25% of grade
⚠️
Severity Score
45/100
20% of grade — higher is better
📅
Recency Score
15/100
15% of grade — recent settlements hurt more

All Settlements Involving Hetero Valsartan $11.37M Drug

Healthcare open

Hetero Valsartan $11.37M Drug Contamination Settlement

Consumers who bought Hetero Valsartan between May 1, 2018, and July 31, 2018, may be eligible to claim a cash payment from a class action settlement.

Amount: $11,370,000 Deadline: Jun 2, 2026
File Claim
🔔

Watch Hetero Valsartan $11.37M Drug

Get notified when new settlements involving Hetero Valsartan $11.37M Drug are filed or when their grade changes.

Set Up Alert
Comparing